HAGOP M. KANTARJIAN, MD
Osteopathic Medicine at Holcombe Blvd, Houston, TX
License number
Texas G5239
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about HAGOP M. KANTARJIAN at radaris.comName
Address
Phone
4510 Oleander St, Bellaire, TX 77401
4567 Elm St, Bellaire, TX 77401
Houston, TX
14 Greenway Plz, Houston, TX 77046
1503 Silverpines Rd, Houston, TX 77062
Organization information
See more information about HAGOP M. KANTARJIAN at bizstanding.comHagop M Kantarjian MD
1515 Holcombe Blvd UNIT 207, Houston, TX 77030
Categories:
Hematology Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Oncology Physicians & Surgeons
Phone:
(713) 792-6161 (Phone)
Professional information
See more information about HAGOP M. KANTARJIAN at trustoria.com
Dr. Hagop M Kantarjian - MD (Doctor of Medicine)
Dr. Hagop M Kantarjian - MD (Doctor of Medicine)
Hospitals:
M.D. ANDERSON CANCER CENTER AT UNIVERSITY OF TEXAS
1515 Holcombe Blvd SUITE 428, Houston 77030
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
M.D. ANDERSON CANCER CENTER AT UNIVERSITY OF TEXAS
1515 Holcombe Blvd SUITE 428, Houston 77030
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
1515 Holcombe Blvd SUITE 428, Houston 77030
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
M.D. ANDERSON CANCER CENTER AT UNIVERSITY OF TEXAS
1515 Holcombe Blvd SUITE 428, Houston 77030
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 207, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
Education:
Medical Schools
AMERICAN UNIVERSITY OF BEIRUT / FACULTY OF MEDICINE
AMERICAN UNIVERSITY OF BEIRUT / FACULTY OF MEDICINE
Hagop M Kantarjian, Houston TX
Hagop M Kantarjian, Houston TX
Specialties:
Oncologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
American University of Beirut, Faculty of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Methods Of Treating Leukemia
Methods Of Treating Leukemia
US Patent:
2003012, Jul 3, 2003
Filed:
Nov 4, 2002
Appl. No.:
10/286960
Inventors:
Jacques Jolivet - Laval, CA
Francis Giles - Houston TX, US
Hagop Kantarjian - Houston TX, US
Francis Giles - Houston TX, US
Hagop Kantarjian - Houston TX, US
Assignee:
Shire BioChem Inc. - Laval
International Classification:
A61K031/675, A61K031/513
US Classification:
514/085000, 514/269000
Abstract:
The present invention provides a novel method for treating leukemia in a host that has been previously treated with a Brc-Abl tyrosine kinase inhibitor comprising administering to the host a therapeutically effective amount of a compound having the formula I:
wherein B is cytosine or 5-fluorocytosine and R is selected from H, monophosphate, diphosphate, triphosphate, carbonyl substituted with a Calkyl, Calkenyl, Calkynyl, Caryl, and
wherein each Rc is independently selected from the group comprising H, Calkyl, Calkenyl, Calkynyl an hydroxy protecting group.
Methods For Treating Cancer
Methods For Treating Cancer
US Patent:
2013021, Aug 22, 2013
Filed:
Nov 4, 2011
Appl. No.:
13/883374
Inventors:
Gautam Borthakur - Houston TX, US
Tapan M. Kadia - Houston TX, US
Hagop M. Kantarjian - Houston TX, US
Sylvie Laquerre - King of Prussia PA, US
Tapan M. Kadia - Houston TX, US
Hagop M. Kantarjian - Houston TX, US
Sylvie Laquerre - King of Prussia PA, US
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED - Brentford
International Classification:
A61K 31/519, A61K 31/436, A61K 45/06, A61K 31/506
US Classification:
5142641
Abstract:
Methods are provided for treating a human having cancer comprising detecting at least one mutation in a Ras protein or a gene encoding at least one Ras protein from at least one tumor cell from said human and treating said human having at least one mutation in at least one Ras protein or a gene encoding at least one Ras protein with a pharmaceutical composition comprising at least one MEK inhibitor comprising a compound of Structure (I):or a pharmaceutically acceptable salt or solvate thereof.